Department of Genetics and Genomic Sciences, Icahn Institute of Genomics and Multiscale Biology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
Department of Data Science, Dana-Farber Cancer Institute, Boston, MA 02215, USA.
Cell Rep Methods. 2021 Jun 21;1(2):100039. doi: 10.1016/j.crmeth.2021.100039.
Patient-derived cell lines are often used in pre-clinical cancer research, but some cell lines are too different from tumors to be good models. Comparison of genomic and expression profiles can guide the choice of pre-clinical models, but typically not all features are equally relevant. We present TumorComparer, a computational method for comparing cellular profiles with higher weights on functional features of interest. In this pan-cancer application, we compare ∼600 cell lines and ∼8,000 tumor samples of 24 cancer types, using weights to emphasize known oncogenic alterations. We characterize the similarity of cell lines and tumors within and across cancers by using multiple datum types and rank cell lines by their inferred quality as representative models. Beyond the assessment of cell lines, the weighted similarity approach is adaptable to patient stratification in clinical trials and personalized medicine.
患者来源的细胞系常用于临床前癌症研究,但有些细胞系与肿瘤差异太大,不能作为良好的模型。基因组和表达谱的比较可以指导临床前模型的选择,但通常并非所有特征都同等相关。我们提出了 TumorComparer,这是一种用于比较细胞谱的计算方法,对感兴趣的功能特征赋予更高的权重。在这项泛癌应用中,我们比较了 24 种癌症类型的约 600 种细胞系和约 8000 个肿瘤样本,使用权重来强调已知的致癌改变。我们使用多种数据类型来描述癌症内和癌症间细胞系和肿瘤的相似性,并根据推断出的代表性模型质量对细胞系进行排名。除了对细胞系的评估之外,加权相似性方法还适用于临床试验和个性化医学中的患者分层。